by The global ophthalmic devices market size accounted for US$ 59.1 billion in 2021 and is projected to reach around USD 78.4 billion by 2030, growing at a CAGR of 3.19% from 2022 to 2030.
Ophthalmic Devices Market Key Takeaway:
- By product, the OCT segment accounted for more than 21% market share in 2021.
- The ophthalmoscopes segment is growing at a CAGR of 5.4% from 2022 to 2030.
- By application, the cataract segment was largest revenue contributor in 2021 and had hold 41.9% in 2021.
- By end use, the hospitals & eye clinics segment has generated market share of over 77% in 2021.
- The North America has accounted substantial market share of over 44% in 2021.
- The Asia Pacific market is growing at a CAGR of around 5.9% in 2021.
Report Summary
The global ophthalmic devices market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the ophthalmic devices market across the globe.
A comprehensive estimate on the ophthalmic devices market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of ophthalmic devices during the forecast period. Price point comparison by region with global average price is also considered in the study.
Ophthalmic Devices Market Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 60.99 Billion |
| Market Size by 2030 | USD 78.4 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 3.19% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, End User, and Geography |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized ophthalmic devices market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Plug-in Hybrid Electric Vehicles (PHEV) Market Report 2030
Ophthalmic Devices Market Players
The report includes the profiles of key ophthalmic devices market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area are Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., Ziemer Ophthalmic Systems AG, Hoya Corporation, HAAG-Streit Holding AG, Johnson & Johnson and Others
Market Segmentation
By Product
- Vision Care Products
- Spectacles
- Contact lenses
- Soft contact lenses
- Rigid gas permeable lenses
- Hybrid contact lenses
- Surgical devices
- Cataract surgical devices
- Intraocular lenses
- Ophthalmic Viscoelastic devices
- Phacoemulsification devices
- Cataract surgical lasers
- IOL Injectors
- Cataract surgical devices
- Vitreoretinal surgical devices
- Vitrectomy machines
- Vitreoretinal packs
- Photocoagulation lasers
- Illumination devices
- Vitrectomy probes
- Refractive surgical devices
- Femtosecond lasers
- Excimer lasers
- Others
- Glaucoma surgical devices
- Glaucoma drainage devices
- Microinvasive glaucoma surgery devices
- Glaucoma laser systems
- Ophthalmic microscopes
- Ophthalmic surgical accessories
- Surgical instruments & kits
- Ophthalmic forceps
- Ophthalmic spatulas
- Ophthalmic tips & handles
- Ophthalmic scissors
- Macular lenses
- Ophthalmic cannulas
- Others
- Diagnostic and monitoring devices
- Optical Coherence Tomography Scanners
- Fundus Cameras
- Perimeters/Visual Field Analyzers
- Autorefractors & Keratometers
- Ophthalmic Ultrasound Imaging Systems
- A-scan ultrasound imaging systems
- B-scan ultrasound imaging systems
- Ultrasound microscopes
- Pachymeters
- Tonometers
- Slit Lamps
- Phoropters
- Wavefront Abberometers
- Optical Biometry Systems
- Ophthalmoscopes
- Lensmeters
- Corneal Topography Systems
- Chart Projectors
- Specular Microscopes
- Retinoscopes
By End User
- Hospitals & Eye Clinics
- Academic & Research Laboratories
- Others
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Ophthalmic Devices Market
5.1. COVID-19 Landscape: Ophthalmic Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Ophthalmic Devices Market, By Product
8.1. Ophthalmic Devices Market, by Product, 2022-2030
8.1.1. Vision Care Products
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Surgical devices
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Vitreoretinal surgical devices
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Refractive surgical devices
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Glaucoma surgical devices
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Ophthalmic microscopes
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Ophthalmic surgical accessories
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.1.8. Diagnostic and monitoring devices
8.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Ophthalmic Devices Market, By End User
9.1. Ophthalmic Devices Market, by End User, 2022-2030
9.1.1. Hospitals & Eye Clinics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Academic & Research Laboratories
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Ophthalmic Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.2. Market Revenue and Forecast, by End User (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End User (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.2. Market Revenue and Forecast, by End User (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.4.2. Market Revenue and Forecast, by End User (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.5.2. Market Revenue and Forecast, by End User (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.6.2. Market Revenue and Forecast, by End User (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.4.2. Market Revenue and Forecast, by End User (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.5.2. Market Revenue and Forecast, by End User (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.6.2. Market Revenue and Forecast, by End User (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.2. Market Revenue and Forecast, by End User (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.4.2. Market Revenue and Forecast, by End User (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.5.2. Market Revenue and Forecast, by End User (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.6.2. Market Revenue and Forecast, by End User (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.2. Market Revenue and Forecast, by End User (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.4.2. Market Revenue and Forecast, by End User (2017-2030)
Chapter 11. Company Profiles
11.1. Novartis AG
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Carl Zeiss Meditec AG
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Essilor International S.A.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Nidek Co., Ltd.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Topcon Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Topcon Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Ziemer Ophthalmic Systems AG
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Hoya Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. HAAG-Streit Holding AG
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Johnson & Johnson
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2241
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
